ArticleHaematologica2018

NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient.

David A Sallman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.